Anecortave acetate.
Clarke
Margo S
MS
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D001682:Biological Availability; D001692:Biological Transport; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy*; D011244:Pregnadienediols / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D011244:Pregnadienediols; C418047:anecortave acetate